These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial. Burkard T; Kaiser CA; Brunner-La Rocca H; Osswald S; Pfisterer ME; Jeger RV; J Intern Med; 2012 Mar; 271(3):257-63. PubMed ID: 21726302 [TBL] [Abstract][Full Text] [Related]
6. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation. Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009 [TBL] [Abstract][Full Text] [Related]
7. Concomitant use of proton pump inhibitors and clopidogrel in patients with coronary, cerebrovascular, or peripheral artery disease in the factores de Riesgo y ENfermedad Arterial (FRENA) registry. Muñoz-Torrero JF; Escudero D; Suárez C; Sanclemente C; Pascual MT; Zamorano J; Trujillo-Santos J; Monreal M; J Cardiovasc Pharmacol; 2011 Jan; 57(1):13-9. PubMed ID: 21164357 [TBL] [Abstract][Full Text] [Related]
8. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry. Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K; Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956 [TBL] [Abstract][Full Text] [Related]
9. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557 [TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome. Gaspar A; Ribeiro S; Nabais S; Rocha S; Azevedo P; Pereira MA; Brandāo A; Salgado A; Correia A Rev Port Cardiol; 2010 Oct; 29(10):1511-20. PubMed ID: 21265493 [TBL] [Abstract][Full Text] [Related]
11. Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors. Valkhoff VE; 't Jong GW; Van Soest EM; Kuipers EJ; Sturkenboom MC Aliment Pharmacol Ther; 2011 Jan; 33(1):77-88. PubMed ID: 21083580 [TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study. Weisz G; Smilowitz NR; Kirtane AJ; Rinaldi MJ; Parvataneni R; Xu K; Stuckey TD; Maehara A; Witzenbichler B; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Stone GW Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26458411 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study. van Boxel OS; van Oijen MG; Hagenaars MP; Smout AJ; Siersema PD Am J Gastroenterol; 2010 Nov; 105(11):2430-6; quiz 2437. PubMed ID: 20736935 [TBL] [Abstract][Full Text] [Related]
14. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes. Gaglia MA; Torguson R; Hanna N; Gonzalez MA; Collins SD; Syed AI; Ben-Dor I; Maluenda G; Delhaye C; Wakabayashi K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R Am J Cardiol; 2010 Mar; 105(6):833-8. PubMed ID: 20211327 [TBL] [Abstract][Full Text] [Related]
15. Current standings of the proton pump inhibitor and clopidogrel co-therapy: review on an evolving field with the eyes of the gastroenterologist. Juhász M; Herszényi L; Tulassay Z Digestion; 2010; 81(1):10-5. PubMed ID: 20029203 [TBL] [Abstract][Full Text] [Related]
16. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study. Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697 [TBL] [Abstract][Full Text] [Related]
17. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial. Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies? Lettino M Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931 [TBL] [Abstract][Full Text] [Related]
19. Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction. Disney BR; Watson RD; Blann AD; Lip GY; Anderson MR Aliment Pharmacol Ther; 2011 Apr; 33(7):758-67. PubMed ID: 21303400 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel. Chen M; Wei JF; Xu YN; Liu XJ; Huang DJ Cardiovasc Ther; 2012 Oct; 30(5):e227-33. PubMed ID: 21884023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]